Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974
Clinicopathologic Conference, Infant Botulism, Case 3-2024
NEJM 390:358-366, Case 3-2024, 2024
A Teenager with Shortness of Breath and Difficulty Walking
Neurol 96:e2346-e2350, Liu, S.C.,et al, 2021
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer
Neurol 91:e985-e994, Touat, M.,et al, 2018
Pembrolizumab-Induced Myasthenia Gravis
Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018
Delirious Deficiency
Lancet 376:1362, Olsen,R.Q &Regis,J.T., 2010
Mitochondrial DNA Polymerase-y and Human Disease
Hum Mol Genet 15:R244-R252, Hudson, G.,et al, 2006
A Six-Year-Old Girl with Tick paralysis
NEJM 342:90-94, Felz,M.W.,et al, 2000
Adult Botulism
Muscle & Nerve, 20:100-10297., Shapiro,B.E.,et al, 1997
Mitochondrial DNA and Disease
NEJM 333:638-644, Johns,D.R., 1995
Neuromuscular Effects of Papuan Taipan Snake Venom
Ann Neurol 38:916-920, Connolly,S.,et al, 1995
Neurologic Manifestations of Giant Cell Arteritis
Am J Med 89:67-72, Reich,K.A.,et al, 1990
Wernicke's Encephalopathy
NEJM 312:1035-1039, Reuler,J.B.,et al, 1985
Clin. Path. Conference
Type B Botulism, Unclassified Form, Case Record 48-1980, NEJM 303:1347-135580., , 1980
Neuropsychiatric Manifest. of SLE:Diagnosis, Clinical Spectrum, & Relationship to Other Features of the Disease
Medicine 55:323, Feinglass,E.J.,et al, 1976
Vincristine Neurotoxicity
Ann Int Med 80:733-737, Rosenthal,S.,et al, 1974
Narcolepsy
NEJM 288:1156, Zarcone,V., 1973
Neurosyphilis
JAMA 219:726, Hooshmand,H.,et al, 1972
Ocular Complications of Vincristine Therapy
Arch Ophthalmol 78:709, Albert,D.M.,et al, 1967